LVIS支架辅助弹簧圈栓塞治疗颅内宽颈动脉瘤的效果观察

张兴业, 贺延莉

张兴业, 贺延莉. LVIS支架辅助弹簧圈栓塞治疗颅内宽颈动脉瘤的效果观察[J]. 实用临床医药杂志, 2019, 23(19): 17-20. DOI: 10.7619/jcmp.201919004
引用本文: 张兴业, 贺延莉. LVIS支架辅助弹簧圈栓塞治疗颅内宽颈动脉瘤的效果观察[J]. 实用临床医药杂志, 2019, 23(19): 17-20. DOI: 10.7619/jcmp.201919004
ZHANG Xingye, HE Yanli. Effect of LVIS stent-assisted spring-ring embolism treatment in patients with intracranial wide cervical aneurysm[J]. Journal of Clinical Medicine in Practice, 2019, 23(19): 17-20. DOI: 10.7619/jcmp.201919004
Citation: ZHANG Xingye, HE Yanli. Effect of LVIS stent-assisted spring-ring embolism treatment in patients with intracranial wide cervical aneurysm[J]. Journal of Clinical Medicine in Practice, 2019, 23(19): 17-20. DOI: 10.7619/jcmp.201919004

LVIS支架辅助弹簧圈栓塞治疗颅内宽颈动脉瘤的效果观察

详细信息
    通讯作者:

    贺延莉

  • 中图分类号: R651.1

Effect of LVIS stent-assisted spring-ring embolism treatment in patients with intracranial wide cervical aneurysm

  • 摘要:
      目的  观察LVIS支架辅助弹簧圈栓塞治疗颅内宽颈动脉瘤的效果。
      方法  将130例颅内宽颈动脉瘤患者分为对照组与观察组, 每组65例。对照组接受弹簧圈栓塞手术治疗,观察组接受LVIS支架辅助弹簧圈栓塞治疗。比较2组临床疗效以及随访6个月时的再发责任血管卒中事件发生率、复发率。
      结果  观察组栓塞有效率为98.46%, 显著高于对照组92.30%(P < 0.05)。术后随访6个月,观察组预后良好率、复发率均显著优于对照组(P < 0.05)。对照组有3例出现再发责任血管卒中事件,而观察组未发生此类事件, 2组比较有显著差异(P < 0.05)。
      结论  LVIS支架辅助弹簧圈栓塞治疗颅内宽颈动脉瘤疗效确切,可以提高栓塞成功率,降低复发率。
    Abstract:
      Objective  To observe effect of LVIS stent-assisted spring-ring embolism treatment in patients with intracranial wide cervical aneurysm.
      Methods  A total of 130 patients with intracranial wide cervical aneurysms were divided into control group and observation group, with 65 cases in each group. The control group received spring-ring embolism treatment, while the observation group received LVIS stent-assisted spring-ring embolism treatment. The clinical effect of the two groups was compared, and the recurrence rate and incidence rate of recurrent responsible vascular stroke at 6 months of follow-up were compared as well.
      Results  The effective rate of embolization in observation group was 98.46%, which was significantly higher than 92.30% in control group (P < 0.05). After 6 months of follow-up, the rate of good prognosis and recurrence rate of disease in the observation group were significantly better than those in the control group (P < 0.05). There were 3 cases of recurrent responsible vascular stroke in the control group, but no such event was observed in the observation group. There was a significant difference between the two groups (P < 0.05).
      Conclusion  LVIS stent-assisted spring-ring embolism treatment is effective in treating patients with intracranial wide cervical aneurysms, which can increase the success rate of embolism and reduce the recurrence rate.>
      Objective  To observe effect of LVIS stent-assisted spring-ring embolism treatment in patients with intracranial wide cervical aneurysm.
      Methods  A total of 130 patients with intracranial wide cervical aneurysms were divided into control group and observation group, with 65 cases in each group. The control group received spring-ring embolism treatment, while the observation group received LVIS stent-assisted spring-ring embolism treatment. The clinical effect of the two groups was compared, and the recurrence rate and incidence rate of recurrent responsible vascular stroke at 6 months of follow-up were compared as well.
      Results  The effective rate of embolization in observation group was 98.46%, which was significantly higher than 92.30% in control group (P < 0.05). After 6 months of follow-up, the rate of good prognosis and recurrence rate of disease in the observation group were significantly better than those in the control group (P < 0.05). There were 3 cases of recurrent responsible vascular stroke in the control group, but no such event was observed in the observation group. There was a significant difference between the two groups (P < 0.05).
      Conclusion  LVIS stent-assisted spring-ring embolism treatment is effective in treating patients with intracranial wide cervical aneurysms, which can increase the success rate of embolism and reduce the recurrence rate.
  • 图  1   术前DSA示颈内动脉C6眼段宽颈动脉瘤

    图  2   LVIS支架辅助弹簧圈栓塞术中情况(1)

    图  3   LVIS支架辅助弹簧圈栓塞术中情况(2)

    图  4   LVIS支架辅助弹簧圈栓塞术后造影

    表  1   2组栓塞效果比较[n(%)]

    组别 n 完全栓塞 近全栓塞 部分栓塞 总有效
    对照组 65 56(86.15) 4(6.15) 5(7.69) 60(92.30)
    观察组 65 62(95.38) 2(3.08) 1(1.53) 64(98.46)*
    与对照组比较, *P < 0.05。
    下载: 导出CSV

    表  2   2组并发症及再发责任血管卒中事件比较[n(%)]

    不良事件 对照组(n=65) 观察组(n=65)
    动脉瘤再破裂 1(1.54) 1(1.54)
    弹簧圈不固定 1(1.54) 1(1.54)
    脑血管痉挛及栓塞 2(3.08) 1(1.54)
    再发责任血管卒中事件 3(4.62) 0*
    与对照组比较, *P < 0.05。
    下载: 导出CSV
  • [1] 王超, 孙超.颅内动脉瘤的研究进展[J].中华神经外科杂志, 2017, 33(8): 859-862. doi: 10.3760/cma.j.issn.1001-2346.2017.08.027
    [2] 赵性泉.专题论坛:颅内动脉瘤与蛛网膜下腔出血编者按[J].中国卒中杂志, 2008, 3(5): 330-330. doi: 10.3969/j.issn.1673-5765.2008.05.007
    [3] 姚正健, 黄瑜娟, 黄建煌, 等.弹簧圈血管内栓塞治疗颅内破裂动脉瘤[J].中国微侵袭神经外科杂志, 2017, 22(11): 511-512. doi: 10.11850/j.issn.1009-122X.2017.11.010
    [4] 李永生, 郑伟, 武田飞, 等.可脱弹簧圈血管内栓塞治疗颅内动脉瘤的临床效果分析[J].中国现代药物应用, 2015, 9(13): 97-98. https://www.cnki.com.cn/Article/CJFDTOTAL-ZWYY201513058.htm
    [5] 李艳敏.颅内宽颈动脉瘤应用血管内支架介入治疗的临床效果观察[J].当代医学, 2017, 23(3): 60-61. https://www.cnki.com.cn/Article/CJFDTOTAL-DDYI201703033.htm
    [6] 张洪剑, 杨鹏飞, 方亦斌, 等.LVIS支架辅助弹簧圈治疗颅内未破裂宽颈动脉瘤中国多中心前瞻性登记(Cranial-1)研究设计方案[J].中国脑血管病杂志, 2017, 14(10): 101-105. https://www.cnki.com.cn/Article/CJFDTOTAL-NXGB201710014.htm
    [7] 于嘉, 邓剑平, 李江, 等.LVIS支架辅助弹簧圈栓塞颅内微小宽颈动脉瘤[J].中华神经外科疾病研究杂志, 2017, 16(4): 301-304. https://www.cnki.com.cn/Article/CJFDTOTAL-SJWK201704004.htm
    [8] 秦福创, 林宏卫, 潘剑威.支架辅助弹簧圈栓塞治疗颈内动脉微小宽颈动脉瘤24例[J].中华危重症医学杂志:电子版, 2018, 11(2): 49-53. https://www.cnki.com.cn/Article/CJFDTOTAL-ZWZD201802010.htm
    [9] 邱礼明, 洪映标, 蔡洁波, 等.应用LVIS密网支架辅助弹簧圈栓塞颅内宽颈小动脉瘤32例临床分析[J].中国基层医药, 2017, 24(14): 2110-2111.
    [10] 赵海燕, 贾子昌, 樊东升.颈内动脉狭窄伴未破裂颅内动脉瘤的临床特点及危险因素分析[J].中华内科杂志, 2018, 57(3): 196-200. https://www.cnki.com.cn/Article/CJFDTOTAL-HXYK201705017.htm
    [11] 黄刚, 徐静宜.支架辅助弹簧圈栓塞治疗颅内宽颈动脉瘤的疗效及并发症分析[J].国际医药卫生导报, 2017, 23(22): 3515-3516. https://www.cnki.com.cn/Article/CJFDTOTAL-HCYX201509021.htm
    [12] 罗昱.LVIS支架在颅内动脉瘤中的应用进展[J].国际神经病学神经外科学杂志, 2017, 44(6): 676-679. https://www.cnki.com.cn/Article/CJFDTOTAL-GWSK201706026.htm
    [13] 杨松, 魏明华, 杨远维, 等.Lvis支架在老年颅内宽颈动脉瘤患者栓塞中的应用[J].中华神经外科疾病研究杂志, 2018, 17(2): 83-85. https://www.cnki.com.cn/Article/CJFDTOTAL-SJWK201802024.htm
    [14] 李文帅, 张信芳, 徐文涛, 等.LVIS支架辅助栓塞急性期破裂颅内宽颈动脉瘤[J].中华神经外科杂志, 2018, 34(1): 50-54. https://www.cnki.com.cn/Article/CJFDTOTAL-GWSK202003004.htm
    [15] 许岗勤, 李天晓, 王子亮, 等.LVIS支架在颈内动脉颅内段宽颈动脉瘤介入治疗中的应用[J].中华实验外科杂志, 2016, 33(7): 1853-1855. https://www.cnki.net/KCMS/detail/detail.aspx?dbcode=IPFD&filename=GJNX200907001068&dbname=IPFD9914
  • 期刊类型引用(1)

    1. 陈莹,卞杰. 白蛋白紫杉醇或铂类联合信迪利单抗对晚期胃癌血清CA724、CA19-9、PG水平及疗效的影响. 罕少疾病杂志. 2024(11): 93-95 . 百度学术

    其他类型引用(1)

图(4)  /  表(2)
计量
  • 文章访问数:  174
  • HTML全文浏览量:  111
  • PDF下载量:  3
  • 被引次数: 2
出版历程
  • 收稿日期:  2019-08-10
  • 录用日期:  2019-09-20
  • 网络出版日期:  2021-02-28
  • 发布日期:  2019-10-14

目录

    /

    返回文章
    返回